Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Varga

Showing results (331-340 of 342) with videos related to

Pageof 35
Sort By:
Revista Clinica Espanola|July 29, 2009
[European Guidelines on Cardiovascular Disease Prevention in Clinical Practice. CEIPC 2008 Spanish adaptation]J M Lobos, M A Royo-Bordonada, C Brotons, et al.
ESMO Open|June 13, 2025
Safety overview and management of inavolisib alone and in combination therapies in PIK3CA-mutated, HR-positive, HER2-negative advanced breast cancer (GO39374)V Gambardella, M K Accordino, P L Bedard, et al.
European Journal of Cancer (Oxford, England : 1990)|January 15, 2016
Immune-related adverse events with immune checkpoint blockade: a comprehensive reviewJ M Michot, C Bigenwald, S Champiat, et al.
Frontiers in Oncology|September 23, 2024
Molecular characterization of gliomas and glioneuronal tumors amid Noonan syndrome: cancer predisposition examinedMargaret Shatara, Kathleen M Schieffer, Marilena Melas, et al.
BMC Cancer|August 24, 2025
MRD4U: A path to development for personalized liquid biopsy for children with central nervous system tumorsAnthony R Miller, Tithi Shah, Corinne N Strawser, et al.
Science (New York, N.Y.)|March 14, 2015
Environment and Development. Get the science right when paying for nature's servicesS Naeem, J C Ingram, A Varga, et al.
BMC Genomics|December 5, 2021
Discovery of clinically relevant fusions in pediatric cancerStephanie LaHaye, James R Fitch, Kyle J Voytovich, et al.
Arerugi = [Allergy]|September 20, 2023
M Maurer, M Magerl, S Betschel, et al.
Arerugi = [Allergy]|May 24, 2023
M Maurer, M Magerl, S Betschel, et al.
Nature Human Behaviour|September 24, 2025
Measuring the semantic priming effect across many languagesErin M Buchanan, Kelly Cuccolo, Tom Heyman, et al.
Pageof 35

Showing results (331-340 of 342) with videos related to

Sort By:
Pageof 35
Revista Clinica Espanola|July 29, 2009
[European Guidelines on Cardiovascular Disease Prevention in Clinical Practice. CEIPC 2008 Spanish adaptation]J M Lobos, M A Royo-Bordonada, C Brotons, et al.
ESMO Open|June 13, 2025
Safety overview and management of inavolisib alone and in combination therapies in PIK3CA-mutated, HR-positive, HER2-negative advanced breast cancer (GO39374)V Gambardella, M K Accordino, P L Bedard, et al.
European Journal of Cancer (Oxford, England : 1990)|January 15, 2016
Immune-related adverse events with immune checkpoint blockade: a comprehensive reviewJ M Michot, C Bigenwald, S Champiat, et al.
Frontiers in Oncology|September 23, 2024
Molecular characterization of gliomas and glioneuronal tumors amid Noonan syndrome: cancer predisposition examinedMargaret Shatara, Kathleen M Schieffer, Marilena Melas, et al.
BMC Cancer|August 24, 2025
MRD4U: A path to development for personalized liquid biopsy for children with central nervous system tumorsAnthony R Miller, Tithi Shah, Corinne N Strawser, et al.
Science (New York, N.Y.)|March 14, 2015
Environment and Development. Get the science right when paying for nature's servicesS Naeem, J C Ingram, A Varga, et al.
BMC Genomics|December 5, 2021
Discovery of clinically relevant fusions in pediatric cancerStephanie LaHaye, James R Fitch, Kyle J Voytovich, et al.
Arerugi = [Allergy]|September 20, 2023
M Maurer, M Magerl, S Betschel, et al.
Arerugi = [Allergy]|May 24, 2023
M Maurer, M Magerl, S Betschel, et al.
Nature Human Behaviour|September 24, 2025
Measuring the semantic priming effect across many languagesErin M Buchanan, Kelly Cuccolo, Tom Heyman, et al.
Pageof 35